{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:15:18Z","timestamp":1791357318359,"version":"4.3.1"},"reference-count":39,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,5,12]],"date-time":"2006-05-12T00:00:00Z","timestamp":1147392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:p><jats:bold>Objectives:\u2002<\/jats:bold> Atypical antipsychotic medications are a relatively new, increasingly prominent component of the treatment armamentarium for bipolar disorder. Information on adherence with antipsychotics among individuals with bipolar disorder in general, and atypical antipsychotics in particular, is currently quite limited. Using data from the VA National Psychosis Registry, we examined adherence with antipsychotic medications among patients with bipolar disorder (n\u2003=\u200373,964).<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Antipsychotic medication adherence among veterans with bipolar disorder was evaluated using the medication possession ratio and categorizing patients into three groups: fully adherent, partially adherent and non\u2010adherent. We compared characteristics of bipolar patients who received versus those who did not receive antipsychotic medication, and also identified predictors of poor adherence with antipsychotic medications.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Approximately 45% (n\u2003=\u200332,993) of all individuals with bipolar disorder were prescribed antipsychotic medication. Individuals who were prescribed antipsychotic medications were younger and more often had comorbid substance abuse or post\u2010traumatic stress disorder compared to individuals with bipolar disorder who were not prescribed antipsychotic medication. Just over half (51.9%) of individuals appear to be fully adherent with antipsychotic medications, while 48.1% of individuals are either partially adherent or non\u2010adherent with antipsychotic medications. Factors associated with treatment non\u2010adherence were younger age, minority ethnicity, comorbid substance abuse and homelessness.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Treatment non\u2010adherence is a major issue for close to half of individuals with bipolar disorder prescribed antipsychotic medication. Additional studies are needed to better understand treatment adherence within the full range of pharmacologic therapies among individuals with bipolar disorder.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2006.00314.x","type":"journal-article","created":{"date-parts":[[2006,5,12]],"date-time":"2006-05-12T16:04:42Z","timestamp":1147449882000},"page":"232-241","source":"Crossref","is-referenced-by-count":185,"title":["Treatment adherence with antipsychotic medications in bipolar disorder"],"prefix":"10.1111","volume":"8","author":[{"given":"Martha","family":"Sajatovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Valenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic C","family":"Blow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara","family":"Ganoczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda V","family":"Ignacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,5,12]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"49","article-title":"Treatment adherence in bipolar patients","volume":"1","author":"Colom F","year":"2002","journal-title":"Clinical Approaches Bipolar Disorders"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810360046007"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0924270800035584"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(92)90084-J"},{"key":"e_1_2_7_6_2","first-page":"37","article-title":"Implications of noncompliance on research in affective disorders","volume":"21","author":"Frank E","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_7_7_2","volume-title":"Manic\u2010depressive Illness","author":"Goodwin FK","year":"1990"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1979.01780080040011"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199211000-00004"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0802"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014662"},{"key":"e_1_2_7_12_2","first-page":"568","article-title":"Case manager ratings of the clinical status of dually diagnosed outpatients","volume":"45","author":"Comtois KA","year":"1994","journal-title":"Hosp Community Psychiatry"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0405"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.psy.0000126199.05189.86"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(99)00108-0"},{"key":"e_1_2_7_16_2","first-page":"56","article-title":"Medication non\u2010adherence in bipolar disorder: a patient\u2010centered review of research findings","volume":"3","author":"Perlick DA","year":"2004","journal-title":"Clin Approach Bipolar Disord"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.55.3.264"},{"key":"e_1_2_7_18_2","volume-title":"Practice Guideline for the Treatment of Patients with Bipolar Disorder (Revision)","author":"American Psychiatric Association","year":"2002"},{"issue":"13","key":"e_1_2_7_19_2","first-page":"19","article-title":"An ever\u2010increasing pharmacopoeia for the management of patients with bipolar disorder","volume":"61","author":"Nemeroff CB","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"e_1_2_7_20_2","first-page":"5","article-title":"Bipolar disorders and the effectiveness of novel anticonvulsants","volume":"63","author":"Calabrese JR","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_21_2","first-page":"1","volume-title":"The Expert Consensus Guideline Series: Treatment of Bipolar Disorder 2004","author":"Keck PE","year":"2004"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.4.692"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.52.6.805"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a007076"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200208000-00002"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000114908.90348.f9"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.5.1218"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2002.1r084.x"},{"key":"e_1_2_7_29_2","first-page":"63","article-title":"Acceptance by patients of maintenance lithium treatment","volume":"2","author":"Mukherjee S","year":"1993","journal-title":"Lithium"},{"key":"e_1_2_7_30_2","first-page":"756","volume-title":"Manic Depressive Illness","author":"Jamison KR","year":"1990"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014574"},{"key":"e_1_2_7_32_2","first-page":"87","article-title":"Compliance with maintenance treatment in bipolar disorder","volume":"33","author":"Keck PE","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290050057011"},{"key":"e_1_2_7_34_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3928\/0279-3695-19820701-04","article-title":"Compliance with lithium regimens","volume":"20","author":"Kucera\u2010Bozarth K","year":"1982","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017111"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2004.10.007"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0502"},{"key":"e_1_2_7_38_2","first-page":"292","article-title":"Factors associated with pharmacologic noncompliance in patients with mania","volume":"57","author":"Keck PE","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.57.1.56"},{"key":"e_1_2_7_40_2","volume-title":"Treatment Adherence in Patients with Rapid Cycling Bipolar Disorder: Results from a Clinical Trials Setting","author":"Sajatovic M","year":"2005"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2006.00314.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2006.00314.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T11:08:27Z","timestamp":1696936107000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2006.00314.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,12]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1111\/j.1399-5618.2006.00314.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2006.00314.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,12]]}}}